145 related articles for article (PubMed ID: 15607361)
21. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
[TBL] [Abstract][Full Text] [Related]
22. Rapid induction of P-glycoprotein mRNA and protein expression by cytarabine in HL-60 cells.
Prenkert M; Uggla B; Tina E; Tidefelt U; Strid H
Anticancer Res; 2009 Oct; 29(10):4071-6. PubMed ID: 19846953
[TBL] [Abstract][Full Text] [Related]
23. MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia.
Benderra Z; Faussat AM; Sayada L; Perrot JY; Tang R; Chaoui D; Morjani H; Marzac C; Marie JP; Legrand O
Clin Cancer Res; 2005 Nov; 11(21):7764-72. PubMed ID: 16278398
[TBL] [Abstract][Full Text] [Related]
24. Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy.
Fedasenka UU; Shman TV; Savitski VP; Belevcev MV
Exp Oncol; 2008 Sep; 30(3):248-52. PubMed ID: 18806751
[TBL] [Abstract][Full Text] [Related]
25. Expression of the breast cancer resistance protein in breast cancer.
Faneyte IF; Kristel PM; Maliepaard M; Scheffer GL; Scheper RJ; Schellens JH; van de Vijver MJ
Clin Cancer Res; 2002 Apr; 8(4):1068-74. PubMed ID: 11948115
[TBL] [Abstract][Full Text] [Related]
26. Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.
Damiani D; Tiribelli M; Michelutti A; Geromin A; Cavallin M; Fabbro D; Pianta A; Malagola M; Damante G; Russo D; Fanin R
Leuk Res; 2010 Jul; 34(7):942-5. PubMed ID: 20122734
[TBL] [Abstract][Full Text] [Related]
27. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
van der Pol MA; Broxterman HJ; Pater JM; Feller N; van der Maas M; Weijers GW; Scheffer GL; Allen JD; Scheper RJ; van Loevezijn A; Ossenkoppele GJ; Schuurhuis GJ
Haematologica; 2003 Feb; 88(2):134-47. PubMed ID: 12604403
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G
Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559
[TBL] [Abstract][Full Text] [Related]
29. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
[TBL] [Abstract][Full Text] [Related]
30. The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells.
Brooks TA; O'Loughlin KL; Minderman H; Bundy BN; Ford LA; Vredenburg MR; Bernacki RJ; Priebe W; Baer MR
Invest New Drugs; 2007 Apr; 25(2):115-22. PubMed ID: 17072745
[TBL] [Abstract][Full Text] [Related]
31. BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer.
Nagashima S; Soda H; Oka M; Kitazaki T; Shiozawa K; Nakamura Y; Takemura M; Yabuuchi H; Fukuda M; Tsukamoto K; Kohno S
Cancer Chemother Pharmacol; 2006 Nov; 58(5):594-600. PubMed ID: 16520985
[TBL] [Abstract][Full Text] [Related]
32. Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase.
Ji N; Yuan J; Liu J; Tian S
Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):854-62. PubMed ID: 21106767
[TBL] [Abstract][Full Text] [Related]
33. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups.
Müller P; Asher N; Heled M; Cohen SB; Risch A; Rund D
Leuk Res; 2008 Jun; 32(6):919-29. PubMed ID: 18207572
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of BCRP expression in breast cancer patients].
Maciejczyk A; Szelachowska J; Ekiert M; Matkowski R; Hałoń A; Surowiak P
Ginekol Pol; 2012 Sep; 83(9):681-7. PubMed ID: 23342897
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia.
Sargent JM; Williamson CJ; Maliepaard M; Elgie AW; Scheper RJ; Taylor CG
Br J Haematol; 2001 Nov; 115(2):257-62. PubMed ID: 11703319
[TBL] [Abstract][Full Text] [Related]
37. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
Kovalev AA; Tsvetaeva DA; Grudinskaja TV
Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
[TBL] [Abstract][Full Text] [Related]
38. Silencing the breast cancer resistance protein expression and function in caco-2 cells using lentiviral vector-based short hairpin RNA.
Zhang W; Li J; Allen SM; Weiskircher EA; Huang Y; George RA; Fong RG; Owen A; Hidalgo IJ
Drug Metab Dispos; 2009 Apr; 37(4):737-44. PubMed ID: 19131524
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer resistance protein (BCRP) gene expression in a cohort of adult Egyptian patients with acute myeloid leukemia.
El-Masry MW; Gouda HM; Shaheen IA; Edesa W; Hassan NM; Ramzy R
Afr Health Sci; 2018 Dec; 18(4):958-964. PubMed ID: 30766560
[TBL] [Abstract][Full Text] [Related]
40. Suppression of BCRP expression and restoration of sensitivity to chemotherapy in multidrug-resistant HCC cell line HEPG2/ADM by RNA interference.
Li H; Zhou S; Li T; Liu Z; Wu J; Zeng G; Liu C; Gong J
Hepatogastroenterology; 2012 Oct; 59(119):2238-42. PubMed ID: 23435138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
